Children and SARS-CoV-2.


Journal

Cell host & microbe
ISSN: 1934-6069
Titre abrégé: Cell Host Microbe
Pays: United States
ID NLM: 101302316

Informations de publication

Date de publication:
14 07 2021
Historique:
entrez: 15 7 2021
pubmed: 16 7 2021
medline: 30 7 2021
Statut: ppublish

Résumé

A previously immune-naive world population is experiencing natural infection with SARS-CoV-2. Severe COVID-19 predominantly impacts adults, yet multisystem inflammatory disorder primarily impacts children. Herein, we discuss known clinical and biological features of SARS-CoV-2 in children and reflect on currently identified immune features and discuss what remains unknown.

Identifiants

pubmed: 34265242
pii: S1931-3128(21)00297-3
doi: 10.1016/j.chom.2021.06.015
pmc: PMC8279573
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1040-1042

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

JAMA. 2020 Jul 21;324(3):259-269
pubmed: 32511692
Science. 2020 Oct 23;370(6515):
pubmed: 32972995
Immunity. 2020 Jun 16;52(6):910-941
pubmed: 32505227
Cell. 2020 Nov 12;183(4):968-981.e7
pubmed: 32966765
J Clin Invest. 2021 May 17;131(10):
pubmed: 33705359
Cell Rep. 2021 Mar 16;34(11):108852
pubmed: 33730580
PLoS Med. 2016 Mar 24;13(3):e1001977
pubmed: 27011229
JAMA Netw Open. 2021 Apr 1;4(4):e215298
pubmed: 33835179
Mod Pathol. 2020 Nov;33(11):2104-2114
pubmed: 32561849
Cell. 2020 Nov 12;183(4):982-995.e14
pubmed: 32991843
Lancet Child Adolesc Health. 2020 Sep;4(9):653-661
pubmed: 32593339
Sci Immunol. 2021 Mar 2;6(57):
pubmed: 33653907
Immunity. 2021 May 11;54(5):1083-1095.e7
pubmed: 33891889
J Exp Med. 2021 Jun 7;218(6):
pubmed: 33904890
JAMA Pediatr. 2020 Sep 01;174(9):882-889
pubmed: 32320004
BMJ. 2020 May 22;369:m1985
pubmed: 32444460

Auteurs

Dusan Bogunovic (D)

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Center of Inborn Errors of Immunity, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Pediatrics, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological science, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: dusan.bogunovic@mssm.edu.

Miriam Merad (M)

Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Department of Oncological science, Icahn School of Medicine at Mount Sinai, New York, NY, USA; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. Electronic address: miram.merad@mssm.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH